Fully bioresorbable scaffolds for coronary artery disease
This KCE has read for you was prepared by Lorena San Miguel, Nadia Benahmed
- Percutaneous coronary intervention (PCI) with stents is the most common procedure to restore blood flow in the management of obstructive coronary artery disease. Recently, Bioresorbable Vascular Scaffolds/stents, made from a naturally resorbable material, have been presented as an alternative to other PCI techniques.
- According to a systematic review published by Ludwig Boltzmann Institute for Health Technology Assessment in March 2015, the available evidence is currently insufficient to show that Bioresorbable Vascular Scaffolds/stents are at least as effective and safer than drug eluting stents in coronary artery disease. The authors recommend to re-assess the evidence in 2018, when results from some of the ongoing trials are expected to become available.
KCE has read for you synthesises a recently published high-quality systematic review or health technology assessment with relevance for the Belgian health system.
The original publication was appraised and contextualised by KCE researchers. KCE has read for you is not based on original research conducted by KCE.
More details on methodology can be found on the KCE website.
This document includes
- Key findings of the publication under evaluation
- A contextualisation within the Belgian healthcare system
- Detailed descriptions
Trustworthy original publication
The methodological quality of the systematic review was assessed with the AMSTAR tool.